Adynamic Bone Disease in Chronic Kidney Disease: From PTH Suppression-Driven Remodeling Phenotype to Osteoanabolic Therapy.

Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB

http://www.ncbi.nlm.nih.gov/pubmed/42671953

Chia-Chao Wu; Chien-Lin Lu; Kuo-Cheng Lu; Kuo-Chin Hung; Te-Chao Fang; Yi-Chou Hou

Sep 1, 2026